2019-2020

Continued to consolidate WEGO Intervention Business Group and its subsidiaries, acquired a controlling stake in NeuroVasc Technologies, Inc., and launched the XINSORB® Bioresorbable Sirolimus-eluting Scaffolds, Aortic Stent Grafts System, and Retriever for Mechanical Thrombectomy.

Released products:

Coronary Stent
Central Venous Catheter
Disposable Blood Pressure Transducer

You may be interested